1. Abernethy DR, Greenblatt DJ. Pharmacokinetics of drugs in obesity. Clin Pharmacokinet 1982;7:108-124.

2. Abernethy DR, Greenblatt DJ. Drug disposition in obese humans: an update. Clin Pharmacokinet 1986;11:199-213.

3. Abernethy DR, Kerzner L. Age effects on alpha-1-acid glycoprotein concentration and imipramine plasma protein binding. J Am Geriatr Soc 1984;32:705-708.

4. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther 1985; 232:183-188.

5. Barlett HL, Puhl SM, Hodgson JL, Buskirk ER. Fat-free mass in relation to stature: ratios of fat-free mass to height in children, adults, and elderly subjects. Am J Clin Nutr 1991;53:1112-1116.

6. Barnhill JG, Greenblatt DJ, Miller LG, Gaver A, Harmatz JS, Shader RI. Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals. J Pharmacol Exp Ther 1990;253:1153-1161.

7. Bayer AJ, Pathy MSJ, Ankier SI. Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol 1983;16:371-376.

8. Benetello P, Furlanut M, Zara G, Baraldo M. Imipramine pharmacokinetics in depressed geriatric patients. Int J Clin Pharmacol Res 1990;10:191-195.

9. Blazer D. Depression in the elderly. N Engl J Med 1989;320:164-166.

10. Cholerton S, Daly AK, Idle JR. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 1992;13:434-439.

11. Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, Glynn RJ, Ostfeld AM, Guralnik JM. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992;47:M137-M144.

12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.

13. Durnas C, Loi C-M, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990;19:359-389.

14. Ellenbroek BA. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. Pharmacol Ther 1993;57:1-78.

15. Evans MA, Triggs EJ, Cheung M, Broe GA, Creasey H. Gastric emptying rate in the elderly: implications for drug therapy. J Am Geriatr Soc 1981;29:201-205.

16. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970;19:653-663.

17. Friedman H, Greenblatt DJ. Rational therapeutic drug monitoring. JAMA 1986;256:2227-2233.

18. Friedman JR, Norman DC, Yoshikawa TT. Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. J Am Geriatr Soc 1989;37:145-149.

19. Froemming JS, Lam YWF, Jann MW, Davis CM. Pharmacokinetics of haloperidol. Clin Pharmacokinet 1989;17:396-423.

20. Furlanut M, Benetello P. The pharmacokinetics of tricyclic antidepressant drugs in the elderly. Pharmacol Res 1990;22:15-25.

21. Geokas MC, Haverback BJ. The aging gastrointestinal tract. Am J Surg 1969;117:881-892.

22. Greenblatt DJ. Pharmacokinetic principles in clinical practice (Clinical Therapeutic Conference). J Clin Pharmacol 1992;32:118-123.

23. Greenblatt DJ. Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 1979;27:20-22.

24. Greenblatt DJ. Presystemic extraction: mechanisms and consequences. J Clin Pharmacol 1993;33:650-656.

25. Greenblatt DJ, Koch-Weser J. Clinical pharmacokinetics. N Engl J Med 1975;293:702-705, 964-970.

26. Greenblatt DJ, Abernethy DR, Shader RI. Pharmacokinetic aspects of drug therapy in the elderly. Ther Drug Monit 1986;8:249-255.

27. Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI. Alprazolam kinetics in the elderly: relation to antipyrine disposition. Arch Gen Psychiatry 1983;40:287-290.

28. Greenblatt DJ, Divoll M, Abernethy DR, Shader RI. Physiologic changes in old age: relation to altered drug disposition. J Am Geriatr Soc 1982;30(suppl):s6-s10.

29. Greenblatt DJ, Friedman H, Burstein ES, Scavone JM, Blyden GT, et al. Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacol Ther 1987;42:193-200.

30. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations. Clin Pharmacokinet 1991;21:165-177, 262-273.

31. Greenblatt DJ, Harmatz JS, Shader RI. Plasma alprazolam concentrations: relation to efficacy and side effects in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:715-722.

32. Greenblatt DJ, Sellers EM, Koch-Weser J. Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol 1982;22:259-263.

33. Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. N Engl J Med 1982;306:1081-1088.

34. Greenblatt DJ, Shader RI, Harmatz JS. Implications of altered drug disposition in the elderly: studies of benzodiazepines. J Clin Pharmacol 1989;29:866-872.

35. Guengerich FP. Human cytochrome P-450 enzymes. Life Sci 1992;50:1471-1478.

36. Hardy BG, Shulman KI, MacKenzie SE, Kutcher SP, Silverberg JD. Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol 1987;7:153-158.

37. Harmatz JS, Greenblatt DJ. Falling off the straight line: some hazards of correlation and regression. J Clin Psychopharmacol 1992;12:75-78.

38. Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1992;52:453-457.

39. Hewick DS, Newbury P, Hopwood S, Naylor G, Moody J. Age as a factor affecting lithium therapy. Br J Clin Pharmacol 1977;4:201-205.

40. Holt PR, Balint JA. Effects of aging on intestinal lipid absorption. Am J Physiol 1993;264:G1-G6.

41. Horowitz M, Maddern GJ, Chatterton BE, Collins PJ, Harding PE, Shearman DJC. Changes in gastric emptying rates with age. Clin Sci 1984;67:213-218.

42. Koch-Weser J, Sellers EM. Binding of drugs to serum albumin. N Engl J Med 1976;294:311-316, 526-531.

43. Levi M, Rowe JW. Aging and the kidney. In: Schrier RW, Gottschalk W, eds. Diseases of the kidney. Boston: Little Brown and Co, 1988;2657-2679.

44. Lindeman RD. Changes in renal function with aging: implications for treatment. Drugs Aging 1992;2:423-431.

45. Loi C-M, Vestal RE. Drug metabolism in the elderly. Pharmacol Ther 1988;36:131-149.

46. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984;251:375-379.

47. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989;321:303-309.

48. Moore JG, Tweedy C, Christian PE, Datz FL. Effect of age on gastric emptying of liquid-solid meals in man. Dig Dis Sci 1983;28:340-344.

49. Moschitto LJ, Greenblatt DJ. Concentration-independent plasma protein binding of benzodiazepines. J Pharm Pharmacol 1983;35:179-180.

50. Murray M. P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992;23:132-146.

51. Nicoll SR, Sainsbury R, Bailey RR, King A, Frampton C, Elliot JR, Turner JG. Assessment of creatinine clearance in healthy subjects over 65 years of age. Nephron 1991;59:621-625.

52. Pond SM, Tozer TN. First-pass elimination: basic concepts and clinical consequences. Clin Pharmacokinet 1984;9:1-25.

53. Regier DA, Boyd JH, Burke JD, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ. One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 1988;45:977-986.

54. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988;8:385-401.

55. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. Age-adjusted standards for creatinine clearance. Ann Intern Med 1976;84:567-568.

56. Salive ME, Cornoni-Huntley J, Phillips CL, Guralnik JM, Cohen HJ, Ostfeld AM, Wallace RB. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol 1992;45:213-221.

57. Sallee FR, Pollock BG. Clinical pharmacokinetics of imipramine and desipramine. Clin Pharmacokinet 1990;18:346-364.

58. Schmucker DL. Aging and drug disposition: an update. Pharmacol Rev 1985;37:133-148.

59. Schultz P, Turner-Tamiyasu K, Smith G, Giacomini KM, Blaschke TF. Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther 1983;33:360-366.

60. Schwartz RS, Shuman WP, Bradbury VL, Cain KC, Fellingham GW, Beard JC, Kahn SE, Stratton JR, Cerqueira MD, Abrass IB. Body fat distribution in healthy young and older men. J Gerontol 1990;45:M181-M185.

61. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med 1993;328:1398-1405.

62. Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R. Studies in the distribution of body fat. I. Effects of age, sex, and obesity. J Gerontol 1989;44:M66-M73.

63. du Souich P, Verges J, Erill S. Plasma protein binding and pharmacological response. Clin Pharmacokinet 1993;24:435-440.

64. Thompson TL, Moran MG, Nies AS. Psychotropic drug use in the elderly. N Engl J Med 1983;308:134-138, 194-199.

65. Tumer N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol 1992;32:271-302.

66. Uhlenhuth EH, Balter MB, Mellinger GD, Cisin IH, Clinthorne J. Symptom checklist syndromes in the general population: correlations with psychotherapeutic drug use. Arch Gen Psychiatry 1983;40:1167-1173.

67. Vallner JJ. Binding of drugs by albumin and plasma protein. J Pharm Sci 1977;66:447-465.

68. van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993;24:203-220.

69. Vestal RE. Pharmacology and aging. J Am Geriatr Soc 1982;30:191-200.

70. von Moltke LL, Greenblatt DJ, Shader RI. Clinical pharmacokinetics of antidepressants in the elderly: therapeutic implications. Clin Pharmacokinet 1993;24:141-160.

71. von Moltke LL, Greenblatt DJ, Harmatz JS, Shader RI. Cytochromes in psychopharmacology. J Clin Psychopharmacol 1994;14:1-4.

72. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987;39:1-47.

73. Wilkinson GR, Shand DG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 1975;18:377-390.

74. Wood M. Plasma drug binding: implications for anesthesiologists. Anesth Analg 1986;65:786-804.

75. Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastrointest Clin North Am 1992;21:511-526.

76. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992;22:1-21.

77. Wysowski DK, Baum C. Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Arch Intern Med 1991;151:1779-1783.

78. Young RC. Hydroxylated metabolites of antidepressants. Psychopharmacol Bull 1991;27:521-532.